Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Selma Düzenli has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prediction of FMF Symptoms with Deep Learning Using Genetic Mutations and Clinical Findings

    by Ali Osman Arslan, Selma Düzenli, Güven Akçay, Meryem Yalçınkaya

    Familial Mediterranean Fever is a hereditary autoinflammatory disorder characterized by recurrent episodes of peritonitis, pleuritis, arthritis, fever, and abdominal pain, with genetic mutations playing a critical role in disease manifestation as well as symptom type and severity. This study aimed to resolve the genotype–phenotype uncertainty in Familial Mediterranean Fever by integrating genetic mutations, demographic characteristics, and clinical data through deep learning methods, thereby enhancing the predictive understanding of symptom development and disease-related risks. A total of 1452 individuals diagnosed with Familial Mediterranean Fever at the Department of Medical Genetics, Bolu Abant İzzet Baysal University Training and Research Hospital between 2016 and 2019 were included. Genetic testing was performed via Real-Time Polymerase Chain Reaction, and clinical data were analyzed using deep learning approaches. Models applied using convolutional neural network, Residual Blocks, and Multi-Head Attention showed strong potential to predict symptom occurrence with high accuracy; specifically, they achieved the highest accuracy and receiver operating characteristic area under the curve for skin rash/redness (accuracy: 90%, Area Under the Curve: 0.873) and joint swelling (accuracy: 88.6%, Area Under the Curve: 0.871). Prediction for chest pain was also strong (Area Under the Curve 0.827), while abdominal pain, joint pain, and fever demonstrated moderate predictive performance (Area Under the Curve 0.719–0.751). Synthetic Minority Over-sampling Technique enhanced prediction for rare symptoms in imbalanced datasets. These findings suggest that deep learning models could contribute to clarifying the relationships between genetic mutations and Familial Mediterranean Fever clinical manifestations; furthermore, they demonstrate a potential to improve the understanding of genotype–phenotype correlations by predicting symptoms and risks, thereby helping to enhance the clinical utility of personalized Familial Mediterranean Fever management.

  • Open Access

    Investigation of rs11568476 Polymorphism in the SLC13A2 Gene in Turkish Patients with Hypocitraturia and Calcium-Containing Kidney Stones

    by Ekrem Başaran, Dursun Baba, Yusuf Şenoğlu, Alpaslan Yüksel, Muhammet Ali Kayıkçı, Selma Düzenli, Ali Tekin

    Background and Objectives: Hypocitraturia is a major risk factor for calcium-containing kidney stone disease. Citrate inhibits stone formation by binding calcium in the urine. The SLC13A2 gene encodes the sodium-dependent dicarboxylate cotransporter 1 (NaDC1), a membrane transport protein that facilitates citrate reabsorption in the proximal renal tubules. Variants in this gene, such as rs11568476 (V477M), have been shown to significantly impair transporter activity. This study aimed to investigate the presence of the rs11568476 polymorphism in SLC13A2 and its association with hypocitraturia in Turkish patients with calcium-containing kidney stones. To our knowledge, this is the first genetic study evaluating this polymorphism in a Turkish cohort. Materials and Methods: This prospective cross-sectional study included 90 patients diagnosed with calcium-containing kidney stones at Düzce University Faculty of Medicine, Department of Urology. Based on 24 h urinary citrate levels, patients were divided into two groups: normocitraturic (n = 38) and hypocitraturic (n = 52). Blood and 24 h urine samples were analyzed for biochemical parameters. The rs11568476 polymorphism in SLC13A2 was analyzed using Real-Time PCR. Results: There were no significant differences between the two groups in terms of age, gender, and most biochemical parameters. Serum uric acid levels were significantly higher in the hypocitraturic group (p = 0.002), whereas family history of stone disease was more prevalent in the normocitraturic group (p = 0.024). Genetic analysis revealed no polymorphism in the rs11568476 region; all patients exhibited the homozygous wild-type genotype (GG). Conclusions: No association was observed between the rs11568476 polymorphism and hypocitraturia in this cohort. The absence of the polymorphism suggests that this variant may be rare or absent in the Turkish population. These findings highlight the importance of investigating additional genetic and environmental contributors to hypocitraturia and nephrolithiasis through larger, multicenter studies.

  • CYP2C9 VE VKORC1 GENLERİNİN PROSTAT KANSERİ ETYOLOJİSİNDEKİ ROLLERİNİN ARAŞTIRILMASI

    by Ali Osman Arslan, Selma Düzenli̇

    En tr 1. Objective: In our study, we aimed to investigate possible individual and common effects of single nucleotide polymorphisms of the gene encoding the enzyme cytochrome p450 (CYP) and the gene encoding the enzyme vitamine K epoxide reductase complex subunit 1 (VKORC1) and their subgroups in patients with prostate cancer. The results of the study also will partially reveal the distribution of genotypes specific to our population, which have not yet been addressed in relation to these two genes. 2. Methods: 48 prostate cancer diagnosed patients and 48 healty male individuals were included in our study. The patient group was selected from volunteers with a prostate-diagnosed age range of 49-86. The control group was selected among without prostate cancer and aged 51-86 years individual. Venous blood was taken from all individuals. Targeted regions were amplified by polymerase chain reaction (PCR) from isolated DNAs. PCR products were genotyped using microarray with appropriate DNA probes. Polymorphisms in the subgroups of the CYP2C9 and VKORC1 gene regions were identified. The results were calculated using the EpiInfo 3.5.1 statistical program. 3. Result: The percentages between patient and control groups showed significant differences when the subgroup polymorphisms of genes encoding CYP2C9 and VKORC1 enzymes were compared. For example, the CC allele of VKORC1 6853 G> C polymorphism found to be %25 in the control and %34.5 in the patient group. The CC allele of CYP2C9 * 3 A> C change found %79.16 in the control and %87.5 in the patient group. 4. Conclusion: Significant differences were seen in number and percentage of patients and control groups in our study. As a result of analysis of the subgroups of CYP2C9 gene and of the VKORC1 gene, statistical significance was not observed. But the percentage results show important differences, though we expect statistical significiance when the numbers of individual is increased 1. Amaç: Çalışmamızda, Sitokrom p450 enzimlerini kodlayan CYP ve vitamin K epoksit redüktaz kompleks subünit1 enzimini kodlayan VKORC1 genlerinin alt gruplarındaki tek nükleotit polimorfizmlerinin muhtemel bireysel ve ortak etkilerini prostat kanseri hastalarında araştırmayı amaçladık. Çalışma sonuçları aynı zamanda bu iki gen ile ilgili henüz ortaya konmamış olan bizim populasyonumuza özgü genotip dağılımını da kısmen ortaya koyacaktır. 2. Gereç ve Yöntem: Çalışmamıza 48 prostat kanseri tanılı erkek hasta ve 48 sağlıklı erkek birey dâhil edildi. Hasta grubu prostat tanısı almış yaş aralığı 49-86 olan gönüllü bireylerden seçildi. Kontrol grubu prostat kanseri olmadığı belirlenmiş, 51-86 yaş grubundaki gönüllü bireylerden seçildi. Hasta ve kontrol grubu bireylerinin venöz kanları alınarak genomik DNA izolasyonları yapıldı. İzole edilen DNA’ların ilgili gen bölgeleri polimeraz zincir reaksiyonu (PCR) ile çoğaltıldı. Sonrasında PCR ürünleri mikroarray cihazında özel problar yardımıyla çalışıldı. CYP2C9 ve VKORC1 gen bölgelerine ait alt grupların polimorfizmleri tanımlandı ve EpiInfo 3.5.1 istatistik programı ile anlamlılıkları hesaplandı. 3. Bulgular: Sonuçlarımızda CYP2C9 ve VKORC1 enzimlerini kodlayan genlerin alt gruplarının polimorfizmleri karşılaştırıldığında hasta ve kontrol grubu arasında yüzde olarak önemli farklar görüldü. Örneğin VKORC1 6853 G>C polimorfizmi için kontrol grubunda CC alleli %25 iken hasta grubunda %34,5 olarak tespit edildi. CYP2C9 *3 A>C değişimi için kontrol grubunda CC alleli %79,16 iken hasta grubunda %87,5 olarak tespit edildi. 4. Sonuç: Çalışmamızda sayı ve yüzde olarak hasta ve kontrol grubunda önemli farklar görüldü. CYP2C9 ve VKORC1 geninin alt gruplarının analizleri sonucunda istatistiksel anlamlılık tespit edilmedi. Bunun sebebinin örnek sayısı azlığı ile alakalı olduğu düşünüldü ve ileri çalışmaların konuyu aydınlatacağı düşünüldü.